| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3025379 | Seminars in Thoracic and Cardiovascular Surgery | 2011 | 6 Pages |
Abstract
Local therapy alone (surgery or radiation) leads to poor overall survival in patients with stage III non-small cell lung cancer because most of these patients die of distant metastases. During the past 20 years, studies have focused on developing effective chemotherapy regimens that can be combined with local therapies (surgery and/or radiation). The role of surgery has been evaluated, and the selection criteria for resection have been defined.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jane Yanagawa, Valerie W. Rusch,